These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16275105)

  • 1. 3D QSAR study of hypolipidemic asarones by comparative molecular surface analysis.
    Magdziarz T; Lozowicka B; Gieleciak R; Bak A; Polański J; Chilmonczyk Z
    Bioorg Med Chem; 2006 Mar; 14(5):1630-43. PubMed ID: 16275105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antifeedant activity against Coleoptera and 3D QSAR study of alpha-asarone derivatives.
    Łozowicka B; Kaczyński P; Magdziarz T; Dubis AT
    SAR QSAR Environ Res; 2014; 25(3):173-88. PubMed ID: 24601760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling robust QSAR. 1. Coding molecules in 3D-QSAR--from a point to surface sectors and molecular volumes.
    Gieleciak R; Magdziarz T; Bak A; Polanski J
    J Chem Inf Model; 2005; 45(5):1447-55. PubMed ID: 16180922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-asarone congeners as hypolipidemic agents. Pseudoreceptor versus minireceptor modeling.
    Filipek S; Łozowicka B
    Acta Pol Pharm; 2000 Nov; 57 Suppl():106-9. PubMed ID: 11293234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRID formalism for the comparative molecular surface analysis: application to the CoMFA benchmark steroids, azo dyes, and HEPT derivatives.
    Polanski J; Gieleciak R; Magdziarz T; Bak A
    J Chem Inf Comput Sci; 2004; 44(4):1423-35. PubMed ID: 15272850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
    Poplawski J; Lozowicka B; Dubis AT; Lachowska B; Witkowski S; Siluk D; Petrusewicz J; Kaliszan R; Cybulski J; Strzałkowska M; Chilmonczyk Z
    J Med Chem; 2000 Oct; 43(20):3671-6. PubMed ID: 11020281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidaemic and antiplatelet activity of phenoxyacetic acid derivatives related to alpha-asarone.
    Pérez-Pastén R; García RV; Garduño L; Reyes E; Labarrios F; Tamariz J; Chamorro G
    J Pharm Pharmacol; 2006 Oct; 58(10):1343-9. PubMed ID: 17034657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling robust QSAR. 2. iterative variable elimination schemes for CoMSA: application for modeling benzoic acid pKa values.
    Gieleciak R; Polanski J
    J Chem Inf Model; 2007; 47(2):547-56. PubMed ID: 17381172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and hypolipidemic activity of modified side chain alpha-asarone homologues.
    Cruz A; Garduño L; Salazar M; Martínez E; Jiménez-Vázquez HA; Díaz F; Chamorro G; Tamariz J
    Arzneimittelforschung; 2001; 51(7):535-44. PubMed ID: 11505784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase.
    Medina-Franco JL; López-Vallejo F; Rodríguez-Morales S; Castillo R; Chamorro G; Tamariz J
    Bioorg Med Chem Lett; 2005 Feb; 15(4):989-94. PubMed ID: 15686898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSPR models for the physicochemical properties of halogenated methyl-phenyl ethers.
    Xu HY; Zhang JY; Zou JW; Chen XS
    J Mol Graph Model; 2008 Apr; 26(7):1076-81. PubMed ID: 18060816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico.
    Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW
    J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability-driven 3D pharmacophore mapping of antimycobacterial potential of hybrid molecules combining phenylcarbamoyloxy and N-arylpiperazine fragments.
    Bak A; Kozik V; Malik I; Jampilek J; Smolinski A
    SAR QSAR Environ Res; 2018 Oct; 29(10):801-821. PubMed ID: 30230355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probability issues in molecular design: predictive and modeling ability in 3D-QSAR schemes.
    Polanski J; Gieleciak R; Bak A
    Comb Chem High Throughput Screen; 2004 Dec; 7(8):793-807. PubMed ID: 15578941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative molecular surface analysis (CoMSA) with modified uniformative variable elimination-PLS (UVE-PLS) method: application to the steroids binding the aromatase enzyme.
    Polanski J; Gieleciak R
    J Chem Inf Comput Sci; 2003; 43(2):656-66. PubMed ID: 12653535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D QSAR studies on 1, 3, 4-thiadiazole derivatives: an approach to design novel anticonvulsants.
    Thareja S; Aggarwal S; Verma A; Bhardwaj TR; Kumar M
    Med Chem; 2010 Jul; 6(4):233-8. PubMed ID: 20843285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.